166 related articles for article (PubMed ID: 26944473)
1. Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes.
Buesche G; Teoman H; Giagounidis A; Göhring G; Schlegelberger B; Ganser A; Aul C; Kreipe HH
Haematologica; 2016 May; 101(5):e177-81. PubMed ID: 26944473
[No Abstract] [Full Text] [Related]
2. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes.
Bowen DT; Jacobs A; Cotes PM; Lewis TC
Eur J Haematol; 1990 Jan; 44(1):30-2. PubMed ID: 2307217
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of Erythropoiesis in Erythroblastic Islands in the Bone Marrow in Experimental Benzene-Induced Anemia.
Tishevskaya NV; Bolotov AA; Lebedeva YE
Bull Exp Biol Med; 2016 Jul; 161(3):384-7. PubMed ID: 27492403
[TBL] [Abstract][Full Text] [Related]
4. Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
Narukawa K; Masuda A; Takahashi T
Int J Hematol; 2021 Jun; 113(6):775-776. PubMed ID: 33864622
[No Abstract] [Full Text] [Related]
5. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
[TBL] [Abstract][Full Text] [Related]
6. [Bone marrow histological changes in myelodysplastic syndrome and its clinical significance].
Liu XF; Wang BM; Yi FH
Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):675-7, 729. PubMed ID: 1815870
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
8. Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes.
Ali AM; Huang Y; Pinheiro RF; Xue F; Hu J; Iverson N; Hoehn D; Coutinho D; Kayani J; Chernak B; Lane J; Hillyer C; Galili N; Jurcic J; Mohandas N; An X; Raza A
Blood Adv; 2018 Jun; 2(12):1393-1402. PubMed ID: 29903708
[TBL] [Abstract][Full Text] [Related]
9. [The possible role of acid glycosaminoglycans in maintaining erythropoiesis in the bone marrow erythroblastic islands].
Kornilova NV; Zakharov IuM; Rassokhin AG
Fiziol Zh Im I M Sechenova; 1994 Mar; 80(3):83-7. PubMed ID: 7527713
[TBL] [Abstract][Full Text] [Related]
10. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
11. Enhancing mitochondrial function in vivo rescues MDS-like anemia induced by pRb deficiency.
Sen T; Jain M; Gram M; Mattebo A; Soneji S; Walkley CR; Singbrant S
Exp Hematol; 2020 Aug; 88():28-41. PubMed ID: 32629063
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in the myelodysplastic syndromes: a review.
Tricot G; Vlietinck R; Verwilghen RL
Scand J Haematol Suppl; 1986; 45():107-13. PubMed ID: 3515514
[No Abstract] [Full Text] [Related]
13. [The content of ribonucleoproteids in the bone marrow erythroblastic islands in various functional states of erythropoiesis].
Kurenkov EL; Kuznetsov ME; Rassokhin AG; Zakharov IuM
Ross Fiziol Zh Im I M Sechenova; 2006 Nov; 92(11):1339-44. PubMed ID: 17385426
[TBL] [Abstract][Full Text] [Related]
14. Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.
Huang H; Xu C; Gao J; Li B; Qin T; Xu Z; Ren S; Zhang Y; Jiao M; Qu S; Pan L; Hu N; Liu J; Cai W; Zhang Y; Wu D; Zhang P; Gale RP; Huang G; Zhou J; Shi L; Xiao Z
Blood Cancer J; 2020 Aug; 10(8):83. PubMed ID: 32801296
[TBL] [Abstract][Full Text] [Related]
15. Role of Plasma Gelsolin Protein in the Final Stage of Erythropoiesis and in Correction of Erythroid Dysplasia In Vitro.
Han SY; Lee EM; Kim S; Kwon AM; Baek EJ
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992584
[TBL] [Abstract][Full Text] [Related]
16. Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.
Sundaravel S; Duggan R; Bhagat T; Ebenezer DL; Liu H; Yu Y; Bartenstein M; Unnikrishnan M; Karmakar S; Liu TC; Torregroza I; Quenon T; Anastasi J; McGraw KL; Pellagatti A; Boultwood J; Yajnik V; Artz A; Le Beau MM; Steidl U; List AF; Evans T; Verma A; Wickrema A
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6359-68. PubMed ID: 26578796
[TBL] [Abstract][Full Text] [Related]
17. Migration of erythroblastic islands toward the sinusoid as erythroid maturation proceeds in rat bone marrow.
Yokoyama T; Etoh T; Kitagawa H; Tsukahara S; Kannan Y
J Vet Med Sci; 2003 Apr; 65(4):449-52. PubMed ID: 12736425
[TBL] [Abstract][Full Text] [Related]
18. Ratio of bone marrow reticulocytes to peripheral corrected reticulocytes for evaluating ineffective erythropoiesis.
Choi JW
Ann Clin Lab Sci; 2006; 36(4):439-41. PubMed ID: 17127730
[No Abstract] [Full Text] [Related]
19. Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes.
Kawai N; Matsuda A; Jinnai I; Ichimura T; Kayano H; Okamura D; Ishikawa M; Maeda T; Hata T; Miyazaki Y; Asou N; Bessho M; Tomonaga M
Int J Hematol; 2016 Feb; 103(2):227-33. PubMed ID: 26608365
[TBL] [Abstract][Full Text] [Related]
20. The erythroblastic island as an emerging paradigm in the anemia of inflammation.
Hom J; Dulmovits BM; Mohandas N; Blanc L
Immunol Res; 2015 Dec; 63(1-3):75-89. PubMed ID: 26376896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
